OPB-51602
Drug timelines are a Plus or Pro feature.
5 regulatory and trial events tracked for OPB-51602, covering 2013-06-03 to 2015-06-19. Get the full timeline:
Most recent: Clinical Trial Update: OPB-51602 in Locally Advanced Nasopharyngeal Carcinoma Prior to Definitive Chemoradiotherapy [Phase 1]